...
首页> 外文期刊>Clinical and diagnostic laboratory immunology >Comparison of a New Immunochromatographic Test to Enzyme-Linked Immunosorbent Assay for Rapid Detection of Immunoglobulin M Antibodies to Hepatitis E Virus in Human Sera
【24h】

Comparison of a New Immunochromatographic Test to Enzyme-Linked Immunosorbent Assay for Rapid Detection of Immunoglobulin M Antibodies to Hepatitis E Virus in Human Sera

机译:新型酶联免疫吸附试验与酶联免疫吸附试验快速检测人血清中戊型肝炎免疫球蛋白M抗体的比较

获取原文
           

摘要

An immunochromatographic test for rapid detection of IgM antibodies in patients with acute hepatitis E infection was developed utilizing the well-characterized recombinant protein EP2.1 and monoclonal antibody 4B2. The new rapid test based on a novel reverse-flow technology was able to generate a positive result within 2 to 3 min. Our study showed that this test was able to detect anti-HEV IgM antibodies in 96.7% of the patient samples tested (n = 151) while maintaining an excellent specificity of 98.6% with samples from various patient or healthy control groups (total n = 208). Furthermore, this rapid test gave a good specificity of 90.9% when tested with rheumatoid factor (RF)-positive sera (RF value of ≤850 IU/ml; n = 11) although a higher concentration of RF in samples might cause cross-reactivity. The new test has a good agreement of 97.2% with a kappa value of 0.943 when compared with a reference enzyme-linked immunosorbent assay. The positive predictive value and the negative predictive value for the rapid test thus reached 98.0 and 97.6%, respectively. This is the first rapid, point-of-care test for hepatitis E and will be especially useful for the diagnosis of acute hepatitis E virus infection in field and emergency settings and in resource-poor countries.
机译:利用特征明确的重组蛋白EP2.1和单克隆抗体4B2,开发了一种用于快速检测急性E型肝炎患者中IgM抗体的免疫色谱测试方法。基于新型逆流技术的新快速测试能够在2-3分钟内产生阳性结果。我们的研究表明,该测试能够在96.7%的患者样本中检测出抗HEV IgM抗体( n = 151),同时对来自不同患者或健康人群的样本保持98.6%的优异特异性对照组(总计 n = 208)。此外,尽管使用较高的RF浓度,但使用类风湿因子(RF)阳性血清(RF值≤850IU / ml; n = 11)进行测试时,该快速测试具有90.9%的良好特异性。在样品中可能会引起交叉反应。与参考酶联免疫吸附试验相比,该新试验具有97.2%的良好一致性,kappa值为0.943。因此,快速测试的阳性预测值和阴性预测值分别达到98.0和97.6%。这是第一个针对戊型肝炎的快速现场检验,对于在野外和紧急情况以及资源匮乏的国家诊断急性戊型肝炎病毒感染特别有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号